I don't get the whiners here who dump on SK and the BOD. Yeah, they've had plenty of shortcomings, but what about the upsides?
IP owned 100%? Check.
Global rights in place? Check.
Manufacturing of lead oncology drug Bavi in-friggin-house?(Are you friggin' kidding me??) Check.
Yes, it's EXTREMELY rare that a small-cap biotech firm manufactures its own drug outright. Think of the savings. In-house. They know their lead drug so well they make it.